This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sunday, M. E. Articles by Witschi, H. Search for Related Content PubMed PubMed Citation Articles by Sunday, M. E. Articles by Witschi, H.

American Journal of Pathology, Vol 147, 740-752, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Histochemical characterization of non-neuroendocrine tumors and neuroendocrine cell hyperplasia induced in hamster lung by 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanone with or without hyperoxia

ME Sunday, CG Willett, SA Graham, VI Oreffo, RI Linnoila and H Witschi
Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.

Lung tumors induced by 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone (NNK) with or without hyperoxia have frequent K-ras mutations but only rare p53 mutations, suggesting that this may be a model for non-small cell lung cancers. The goals of the present study were (1) to characterize the histopathology of lung tumors induced in hamsters by NNK with or without O2 and (2) as a corollary, to quantitate the pulmonary neuroendocrine cell hyperplasia in the different treatment groups early and late in the treatment period. Lung tumors induced by NNK with or without O2 were 71% adenomas, 22% adenocarcinomas, approximately 4% bronchoalveolar carcinomas, and approximately 4% squamous/adenosquamous carcinomas. One-half of all tumors were positive for the Clara cell antigen CC10 and 21% of NNK-induced tumors were mucin positive, compared with 2% of NNK/O2-induced tumors (P = 0.003). Immunostaining for PGP9.5 was positive in 5% of tumors induced by NNK alone, but in none of NNK/O2-induced tumors (P = 0.024). Abundant proliferating cell nuclear antigen occurred in 55% of NNK-induced tumors, compared with 19% of NNK/O2-induced tumors (P = 0.009). These data indicate that NNK with or without O2 induces non-neuroendocrine lung tumors. Hyperoxia appears to inhibit cell proliferation and suppress mucinous and partial neuroendocrine differentiation in some of these tumors.

This article has been cited by other articles:

				R. Haworth, J. Woodfine, S. McCawley, A. M. Pilling, D. J. Lewis, and T. C. Williams Pulmonary Neuroendocrine Cell Hyperplasia: Identification, Diagnostic Criteria and Incidence in Untreated Ageing Rats of Different Strains Toxicol Pathol, August 1, 2007; 35(5): 735 - 740. [Abstract] [Full Text] [PDF]

				R. I. Linnoila, B. Zhao, J. L. DeMayo, B. D. Nelkin, S. B. Baylin, F. J. DeMayo, and D. W. Ball Constitutive Achaete-Scute Homologue-1 Promotes Airway Dysplasia and Lung Neuroendocrine Tumors in Transgenic Mice Cancer Res., August 1, 2000; 60(15): 4005 - 4009. [Abstract] [Full Text]

				L. J. Muglia, D. S. Bae, T. T. Brown, S. K. Vogt, J. G. Alvarez, M. E. Sunday, and J. A. Majzoub Proliferation and Differentiation Defects during Lung Development in Corticotropin-Releasing Hormone-Deficient Mice Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 181 - 188. [Abstract] [Full Text]

				K. J. Haley, K. Patidar, F. Zhang, R. L. Emanuel, and M. E. Sunday Tumor necrosis factor induces neuroendocrine differentiation in small cell lung cancer cell lines Am J Physiol Lung Cell Mol Physiol, August 1, 1998; 275(2): L311 - L321. [Abstract] [Full Text] [PDF]

				C. G. Willett, M.-H. Wang, R. L. Emanuel, S. A. Graham, D. I. Smith, V. Shridhar, D. J. Sugarbaker, and M. E. Sunday Macrophage-stimulating Protein and Its Receptor in Non-small-cell Lung Tumors: Induction of Receptor Tyrosine Phosphorylation and Cell Migration Am. J. Respir. Cell Mol. Biol., April 1, 1998; 18(4): 489 - 496. [Abstract] [Full Text]